Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented ...
Apr 4, 2012
0
1